Publication | Open Access

Design and synthesis of new potent anticancer benzothiazole amides and ureas featuring pyridylamide moiety and possessing dual B-RafV600E and C-Raf kinase inhibitory activities

Combinatorial ChemistryMedicinal ChemistryNatural SciencesMedicineOrganic ChemistryAnti-cancer AgentChemistryPharmacologyPharmaceutical ChemistryDual B-rafv600eDrug Discovery